Search
Displaying 341–350 of 715 for “retinitis clinical trial”
-
The Retina is a Proving Ground for a Broad Range of Neurological Therapies
Research NewsRetinal research paves the way for new treatments for the entire neurological system.
-
ARVO 2018: Dr. Shannon Boye Reports on her Emerging Gene Therapy for LCA (GUCY2D)
Research NewsShannon Boye, PhD, University of Florida, talks about the advancement of her of gene therapy for Leber congenital amaurosis toward a clinical trial.
-
Natural History Study Launches for LCA Caused by Specific Mutation in CEP290
Research NewsThe natural history study will be used to characterize the range of visual function in patients, to evaluate which visual tests may be the most useful for patients with this condition, and to determine the rate of change in visual function over a one-year period.
-
Sight and Song: The Christian Guardino Story
Beacon StoriesChristian Guardino has been singing for as long as he can remember; it’s the seeing that is something new.
-
Nobel-Prize-Winning Stem-Cell Researcher Delivers Keynote at FFB-Funded Conference in Kyoto
Research NewsDr. Shinya Yamanka discussed his early clinical trial for iPSC-derived retinal pigment epithelial (RPE) cells for a 78-year-old woman with advanced wet age-related macular degeneration (AMD).
-
DHA and EPA for Stargardt Disease — an Evolving Story
Research NewsThese healthy fats have exciting potential for treating a wide range of retinal degenerations and other health conditions.
-
Getting the Right Diagnosis for a Retinal Disease
Research NewsDefinitive diagnoses for inherited retinal diseases don’t always come easy, even for the patients of the most knowledgeable doctors.
-
Advocacy Research News
In this in-depth interview hosted by InVivo, Jason Menzo, CEO of the Foundation Fighting Blindness, outlines the organization’s strategy for addressing significant changes and opportunities in the inherited retinal diseases (IRDs).
-
VISIONS 2014 — My Retina Tracker: Track Your Vision and Drive the Research
Research NewsThe powerful and secure system enables patients to keep track of their clinical care and vision changes. At the same time, it enables scientists to search the “de-identified” (i.e., anonymous) patient information to study conditions and identify targets for treatments, preventions and cures.
-
The fiscal year 2025-2029 Science Strategic Plan is developed with a single, overarching goal: To drive research projects and activities to overcome barriers to translating preclinical research into clinical trials for individuals affected by inherited retinal diseases and dry AMD.
